Table 2. Participant characteristics (n = 10).
| Mean | SD | Range | |
|---|---|---|---|
| Age at study-start (years) | 21 | 2.9 | 17–25 |
| Age at cancer diagnosis (years) | 15.9 | 1.4 | 13–17 |
| Time since end of cancer treatment (years) (n = 9) | 3.2 | 1.7 | 1–6 |
| n | |||
| Female/Male | 4/6 | ||
| Cancer diagnosis from self-report | |||
| Leukemia | 4 | ||
| CNS-tumor | 2 | ||
| Lymphoma | 2 | ||
| Soft tissue sarcoma | 1 | ||
| Other malignancy | 1 | ||
| Cancer diagnosis from registry | |||
| Leukemia | 5 | ||
| CNS-tumor | 2 | ||
| Lymphoma | 2 | ||
| Soft tissue sarcoma | 1 | ||
| Other malignancy | 0 | ||
| History of relapse yes/no | 1/9 | ||
| Living situation | |||
| With parents | 6 | ||
| Not with parents | 4 | ||
| Relationship status | |||
| Single | 5 | ||
| In a relationship | 5 | ||
| Employment status | |||
| Student | 6 | ||
| Employed full-time | 1 | ||
| Employed part-time | 2 | ||
| Unemployed | 1 | ||
| Sick leave | 0 | ||
| Self-reported late effects yesa /no | 8/2 | ||
| Previous psychological treatment yes/no | 6/4 |
Notes.
- N/n
- number of participants
- SD
- Standard Deviation
a
Self-reported late effects included anemia, balance problems, fatigue/tiredness, headaches, high blood pressure, kidney stone, loss of appetite, memory problems, nausea, nerve damage, nerve pain, numbness, speech difficulties, and thrombus.